Sign in
Taking people in United StatesNo phase

Long-term follow-up of genicular artery embolization for knee osteoarthritis

Tracks pain and safety after genicular artery embolization in adults with knee osteoarthritis.

Key facts

Who runs it
Joint & Vascular Institute
Where
Libertyville, United StatesSee the site
Trial code
Registry title
geniculaR Artery eMBolization for Knee Osteoarthritis (RAMBO) Registry
Status
Recruiting
People taking part
1,200 people, planned
Started
16 Jul 2025
Expected to end
Jul 2030
Type of study
Observational
Treatments tested
  • Genicular Artery Embolization
Record updated
12 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with knee osteoarthritis that causes symptoms and has not improved with medical therapy. They must be referred for genicular artery embolization (GAE), a procedure that blocks small blood vessels around the knee.

Age
18 years or older
Sex
All sexes
Disease stage
Knee osteoarthritis that causes symptoms
Earlier treatment
Medical therapy was tried and did not help enough

Main reasons for not taking part

  • Pregnancy
  • Blood clotting problems (coagulopathy)
  • Severe other illnesses
  • Not able to give consent

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Adults (≥18 years) with symptomatic KOA refractory to medical therapy, referred for GAE

Who cannot take part

  • Pregnancy, coagulopathy, severe comorbidities, or inability to consent

Where in United States

  • Joint and Vascular InstituteLibertyville, United StatesContact: Layth AlkhaniTaking people

About the trial

What the trial wants to find out

The goal of this observational study (prospective registry) is to collect long-term real-world data on the effectiveness and safety of genicular artery embolization (GAE) for knee osteoarthritis in adults aged 18 years or older with symptomatic KOA that has not responded to medical therapy.

Read full original descriptionShow less

The main questions it aims to answer are:

1. Does GAE lead to sustained improvement in pain (WOMAC, VAS) and quality-of-life scores over 12-36 months? 2. What patient or procedural factors are associated with better outcomes after GAE?

Participants will:

* Undergo GAE as part of their routine clinical care. * Complete clinical follow-up assessments at 1, 3, 6, 12, 18, 24, and 36 months after treatment, including symptom and quality-of-life questionnaires. * Have safety outcomes tracked according to Society of Interventional Radiology guidelines.

There is no comparison group; results will be analyzed to identify predictors of success and inform best practices for patient selection and treatment.

Treatments tested

  • Genicular Artery Embolization

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Creation Of a Prospective Registry For Genicular Artery Embolization At The Joint & Vascular Institute
Plain-language title
Long-term follow-up of genicular artery embolization for knee osteoarthritisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
12 June 2026